Concepedia

Dean L. McCarley

DL

Statistics

Publications

8

Citations

332

H-Index

8

Active since

1983

Affiliations

University of Florida(Current)

Florida College

Dean L. McCarley is an author at University of Florida specializing in medicine, oncology, and chemotherapy.

Publications per year

1983–2005

8

Publications

8

The immunosuppressant leflunomide inhibits lymphocyte progression through cell cycle by a novel mechanism.

Holly Cherwinski, Dean L. McCarley, Randall C. Schatzman et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 101 citations

Life Sciences, Cell Biology, Pharmacology +17

Bladder-sparing multimodality treatment of muscle-invasive bladder cancer: A five-year follow-up

Robert Given, J. Travis Parsons, Dean L. McCarley et al. · Urology · 1995 · 91 citations

Medicine, Oncology, Urology +12

A phase III trial of high-dose cytosine arabinoside with or without etoposide in relapsed and refractory acute myelogenous leukemia. A Southeastern Cancer Study Group trial.

William R. Vogler, Dean L. McCarley, M. Patrick Stagg et al. · PubMed · 1994 · 64 citations

Medicine, Oncology, Pharmacology +16

Purified human monocyte subsets as effector cells in antibody-dependent cellular cytotoxicity (ADCC).

Dean L. McCarley, Virendra O. Shah, Roy S. Weiner · The Journal of Immunology · 1983 · 19 citations · Full text

Life Sciences, Cell Biology, Immunology +11

Topotecan-induced topoisomerase IIα expression increases the sensitivity of the CML cell line K562 to subsequent etoposide plus mitoxantrone treatment

Sheilachu P. Gomez, Dean L. McCarley, Mark Mainwaring · Cancer Chemotherapy and Pharmacology · 2002 · 19 citations

Medicine, Oncology, Pharmacology +11

1–5 of 8